TIG Advisors LLC’s Ra Pharmaceuticals, Inc. Common Stock RARX Stock Holding History

TIG Advisors LLC’s Portfolio RARX Stock Details RARX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-778,714	Closed	-$37.4M	–	70
2020 Q1	$37.4M	Buy	+778,714	New	+$36.2M	1.51%	19

Other funds holding RARX

Daiwa Securities Group Tokyo, Japan $34.8B AUM 20.7% 1-Year Est. Return

TIG Advisors LLC's RARX Position: Q2 2020 in Review

TIG Advisors LLC sold out of Ra Pharmaceuticals, Inc. Common Stock (RARX) in Q2 2020, closing a stake of 778,714 shares — an estimated $37.4M sold.

TIG Advisors LLC first reported a position in RARX in Q1 2020 and held it in 1 quarter. The position peaked at $37.4M in Q1 2020. 1 fund tracked by Wall St. Rank holds RARX as of Q2 2020.

TIG Advisors LLC reported no remaining Ra Pharmaceuticals, Inc. Common Stock position as of Q2 2020 after selling out during the quarter.
TIG Advisors LLC sold 778,714 Ra Pharmaceuticals, Inc. Common Stock shares in Q2 2020, an estimated $37.4M.
TIG Advisors LLC first reported a position in Ra Pharmaceuticals, Inc. Common Stock in Q1 2020 and held it in 1 quarter.
TIG Advisors LLC's Ra Pharmaceuticals, Inc. Common Stock position peaked at $37.4M in Q1 2020.
1 fund tracked by Wall St. Rank held Ra Pharmaceuticals, Inc. Common Stock as of Q2 2020.

Based on TIG Advisors LLC's 13F filing for Q2 2020, filed 14 Aug 2020.